Sign inJoin waitlistJoin the waitlist

Travis Grotz

Program Director · Mayo Clinic College of Medicine and Science

Credentials: · · · · · ·

History

Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present

Complex General Surgical Oncology
University of Texas M D Anderson Cancer Center
2019–2021
General Surgery
Mayo Clinic College of Medicine and Science
2014–2019
MDCreighton University School of Medicine
2011–2014
BASaint John's University
2008–2011
Creighton University School of Medicine
2004–2008
Saint John's University
2000–2004

Research

Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 1,255 citations
Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024 · 922 citations
NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023
Journal of the National Comprehensive Cancer Network · 2023 · 469 citations

Keith Fournier
42 papers
Jordan Cloyd
35 papers · 21 as a fellow
Sameer Patel
35 papers
Laura Lambert
34 papers
Sean Dineen
34 papers
Callisia Clarke
29 papers
Daniel Abbott
29 papers
Fabian Johnston
29 papers
Mustafa Raoof
29 papers
Jennifer Leiting
28 papers · 28 as a resident
Joel Baumgartner
27 papers
Jonathan Greer
27 papers · 1 as a fellow

Clinical trials

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence
Principal investigator · Enrolling by invitation · Phase 2
Mayo Clinic
2025–2031
Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis
Principal investigator · Active not recruiting · Phase 1
Mayo Clinic
2023–2029
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
Principal investigator · Recruiting · Phase 2
Mayo Clinic
2023–2030
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Site PI · Recruiting · Phase 2, Phase 3
ECOG-ACRIN Cancer Research Group
2025–2030